Alkami (ALKT) CEO Sells 75k Shares via 10b5-1 Plan; Remaining 839,493 Shares

Rhea-AI Filing Summary

Alex Shootman, Chief Executive Officer and a director of Alkami Technology, Inc. (ALKT), reported a sale of 75,000 shares of common stock on 08/27/2025, at a weighted-average price of $25.1954 per share (individual trade prices ranged from $24.84 to $25.36). After the reported sale, the reporting person beneficially owned 839,493 shares. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan, and the filer offers to provide details on the number of shares sold at each price within the reported range upon request.

Positive

• Sale executed under a Rule 10b5-1 trading plan, indicating a prearranged schedule rather than an unscheduled insider sale
• Filer offers to provide detailed per-price execution information upon request, supporting transparency

Negative

• Insider sold 75,000 common shares, reducing beneficial ownership to 839,493 shares
• Sale represents a material single-day disposition (75,000 shares) which investors may view as notable

Insights

Financial Analyst

TL;DR: Insider sale of 75,000 shares under a 10b5-1 plan; remaining stake 839,493 shares — routine but notable for size.

The transaction shows a planned disposition rather than an ad hoc sale because it was executed under a Rule 10b5-1 plan, which generally signals pre-scheduled selling. The weighted-average sale price of $25.1954 (range $24.84–$25.36) and the sale size (75,000 shares) are material in absolute terms but the filing does not provide company market-cap or percentage ownership impact. No derivative transactions or other changes to beneficial ownership are reported. For investors, the key datapoints are the sale size, price range, and that the remaining beneficial ownership is 839,493 shares.

Corporate Governance Expert

TL;DR: Disclosure is procedurally complete and identifies the 10b5-1 plan; no governance red flags are evident from this Form 4 alone.

The Form 4 discloses the reporting person’s role as CEO and director and documents a sale pursuant to a Rule 10b5-1 trading plan, which provides affirmative defense to insider trading allegations when properly implemented. The filer attests willingness to supply detailed execution data for the trade prices within the stated range, supporting transparency. The form does not show any other related-party transfers, option exercises, or derivative activity that would raise additional governance concerns.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shootman Alex

(Last) (First) (Middle)

C/O ALKAMI TECHNOLOGY, INC.

5601 GRANITE PARKWAY, SUITE 120

(Street)

PLANO TX 75024

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALKAMI TECHNOLOGY, INC. [ ALKT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/27/2025		S(1)		75,000	D	$25.1954(2)	839,493	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transaction of prices ranging from $24.84 to $25.36. The Reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Douglas A. Linebarger, as Attorney-in-Fact for Alex Shootman	08/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many ALKT shares did Alex Shootman sell on this Form 4?

The filing reports a sale of 75,000 shares executed on 08/27/2025.

At what price were the ALKT shares sold?

The weighted-average sale price reported is $25.1954; individual trade prices ranged from $24.84 to $25.36.

How many ALKT shares does the reporting person own after the sale?

Following the reported transaction, the reporting person beneficially owned 839,493 shares.

Was the sale executed under a trading plan or ad hoc?

The Form 4 states the sales were effected pursuant to a Rule 10b5-1 trading plan.

Does the Form 4 show any option exercises or derivative transactions by the reporting person?

No. Table II (derivative securities) shows no reported derivative transactions in this filing.